SUMMIT FINANCIAL GROUP, INC. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
SUMMIT FINANCIAL GROUP, INC. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2022$482
-99.9%
9,4550.0%0.19%
-9.5%
Q3 2022$509,000
-16.1%
9,4550.0%0.21%
-9.8%
Q2 2022$607,000
-17.2%
9,4550.0%0.23%
-5.6%
Q1 2022$733,000
-9.7%
9,4550.0%0.25%
-6.1%
Q4 2021$812,000
+6.8%
9,4550.0%0.26%
-4.0%
Q3 2021$760,000
-0.1%
9,4550.0%0.28%
-3.5%
Q2 2021$761,000
-4.5%
9,4550.0%0.28%
-13.9%
Q1 2021$797,000
+5.0%
9,4550.0%0.33%
-0.3%
Q4 2020$759,000
-0.1%
9,4550.0%0.33%
-11.9%
Q3 2020$760,000
-6.6%
9,4550.0%0.38%
-11.1%
Q2 2020$814,000
+6.0%
9,4550.0%0.42%
-7.4%
Q1 2020$768,000
-2.9%
9,4550.0%0.46%
+20.8%
Q4 2019$791,000
-17.8%
9,455
-14.0%
0.38%
-22.5%
Q3 2019$962,000
+4.5%
11,000
-2.2%
0.49%
+17.5%
Q2 2019$921,000
+0.7%
11,2500.0%0.42%
-41.8%
Q1 2019$915,000
+23.6%
11,2500.0%0.72%
+13.9%
Q4 2018$740,000
-14.6%
11,2500.0%0.63%
-2.8%
Q3 2018$867,000
-10.1%
11,250
-13.8%
0.65%
-13.9%
Q2 2018$964,000
+13.5%
13,0500.0%0.75%
+13.0%
Q1 2018$849,000
+16.8%
13,050
+16.0%
0.66%
+11.6%
Q4 2017$727,000
+3.0%
11,2500.0%0.60%
+1.2%
Q3 2017$706,000
+3.7%
11,2500.0%0.59%
-0.3%
Q2 2017$681,00011,2500.59%
Other shareholders
BAXTER INTL INC shareholders Q3 2021
NameSharesValueWeighting ↓
GENERATION INVESTMENT MANAGEMENT LLP 21,171,371$1,817,350,0007.47%
Soditic Asset Management LLP 147,620$12,672,0006.53%
NUANCE INVESTMENTS, LLC 4,084,218$350,589,0006.17%
PRAGMA GESTAO DE PATRIMONIO LTD 145,000$12,4475.96%
Veritas Asset Management LLP 12,222,261$1,049,159,0005.89%
Pavadi Capital LLC 72,782$6,248,0004.74%
Sonen Capital LLC 48,907$4,198,0004.06%
Glenview Capital Management 2,182,422$187,339,0003.99%
Dash Acquisitions Inc. 103,963$8,924,0003.87%
Avidity Partners Management LP 1,765,000$151,508,0003.21%
View complete list of BAXTER INTL INC shareholders